David Eckland
Geen lopende functies
Profiel
David Eckland worked as the International Director-Metabolic Disease Clinic at Glaxo Wellcome Plc from 1990 to 1997.
He then worked as the Director-Research & Development at Ark Therapeutics Group Plc, followed by Managing Director at Takeda Europe Research & Development Centre.
He was also a Member at The Royal College of Physicians.
Eckland holds a doctorate degree from Imperial College London and the University of London.
Eerdere bekende functies van David Eckland
| Bedrijven | Functie | Einde |
|---|---|---|
| Glaxo Wellcome Plc | Corporate Officer/Principal | 01-01-1997 |
Takeda Europe Research & Development Centre
 Takeda Europe Research & Development Centre Miscellaneous Commercial ServicesCommercial Services Takeda Europe Research & Development Centre is a British company that specializes in Biological Research. The private company is based in London, UK. | Corporate Officer/Principal | - |
| The Royal College of Physicians | Corporate Officer/Principal | - |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van David Eckland
| Imperial College London | Doctorate Degree |
| University of London | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
| Glaxo Wellcome Plc | Health Technology |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
Takeda Europe Research & Development Centre
Takeda Europe Research & Development Centre Miscellaneous Commercial ServicesCommercial Services Takeda Europe Research & Development Centre is a British company that specializes in Biological Research. The private company is based in London, UK. | Commercial Services |
